Serum p53 antibodies in small cell lung cancer: The lack of prognostic relevance

Lung Cancer

Volumn 31, Issue 1, 2001, Pages 17-23

  Jassem, Ewa ^a   Bigda, Jacek ^a   Dziadziuszko, Rafał ^a   Schlichtholz, Beata ^a,b   Le Roux, Delphine ^b   Grodzki, Tomasz ^c   Rzyman, Witold ^a   Konopa, Krzysztof ^a   Poberezna, Marta ^a   Dobrzańska, Zuzanna ^a   Skokowski, Jan ^a   Soussi, Thierry ^b   Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b INSTITUT CURIE   (France)

^c Regional Hospital of Chest Diseases In Zdunowo   (Poland)

Author keywords

p53 antibodies; Prognostic value; Serum autoantibodies; Small cell lung cancer

Indexed keywords

ANTIBODY; AUTOANTIBODY; PROTEIN P53;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENDER; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SERUM;

ADULT; AGED; ANTIBODIES, NEOPLASM; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035201655     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00150-1     Document Type: Article

References (22)

1. Serum anti-p53 autoantibodies in primary resected non-small-cell lung carcinoma
2. p53 antibodies in the sera of lung cancer patients: comparison with p53 mutation in the tumor tissue
3. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation
4. Clinical implications of molecular abnormalities in lung cancer
5. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients
6. Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein
7. Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer
8. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study
9. Clinical implications of serum anti-p53 antibodies for patients with gastric carcinoma
10. Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lung
11. Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer
12. Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer
13. Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancer
14. Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface
15. p53 antibodies in patients with various types of cancer: assay, identification and characterization
16. Serum p53 antibodies as early markers of lung cancer
17. Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment
18. p53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy
19. Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer
20. Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival
21. Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer